Finding springtime relief: Allergy season by the numbers

Finding springtime relief: Allergy season by the numbers

04.02.2025

Listen

·
Finding springtime relief: Allergy season by the numbers
Finding springtime relief: Allergy season by the numbers

Allergy season is in full bloom. Spring’s warmer temperatures have combined with pollen counts increasing in many parts of the U.S. — in some places, the dust could even be growing into a year-round visitor.1

Pollen from trees, grasses, and weeds can trigger allergic rhinitis (commonly known as “hay fever”), which affects up to 60 million Americans. The resulting sneezing, runny nose, and congestion can be the body’s way of responding to the allergen — and treating symptoms has been adding up.2

Off-the-shelf solutions

Seasonal allergies can drive big business, with the $22.8 billion global allergy treatment market expected to grow to more than $42 billion by 2034.3

Allergy medications without a prescription are one option to fight the battle against pollen, and here’s how American shoppers have been spending on over-the-counter (OTC) solutions:4

  • Nearly two-thirds of U.S. households buy over-the-counter allergy medications, spending an average of $58.

  • During allergy season, 60% of buyers take these medications daily.

  • 70% of shoppers reported using only OTC medications, while 30% said they supplement these with prescription medicines.

  • April sees the highest amount of allergy medication sales (11.3% of annual sales in 2023).

Allergies may be part of what’s in the air when it comes to seasonal credit card expenses: In April 2024, people spent $398.64 on healthcare and medical expenses overall, a 5.27% year-over-year jump, according to Empower Personal DashboardTM data.

The majority of consumers (72%) think store-brand and name-brand allergy medications offer the same quality.5 That’s not stopping pharmaceutical companies from investing in getting their brand names into consumers’ minds. Ad spending for the healthcare and pharma sector was expected to top $30 billion in 2024.6

This year, OTC brand Allegra formed a partnership with Disney’s live-action “Snow White” movie release through in-store displays and media ads — tying seasonal allergies to a cultural moment.7

Taking another shot

For people who need a stronger dose of medicine, allergy shots could be a longer-lasting option with a higher price tag.

The injections, also known as immunotherapy, include trace amounts of allergens, intending to desensitize people to their triggers and strengthen the immune system. Immunotherapy can be given to people 5 and older, with 80% seeing significant improvement in their symptoms.8

Depending on health insurance, allergists, and other factors, paying for allergy shots can run between $1,000 and $4,000 each year.9

Paying the price

Spending on healthcare has been on the rise in the U.S., growing 7.5% in 2023 and amounting to more than $14,500 per person.10 Considering how to balance out-of-pocket spending and potential tax savings can be important for people juggling recurring allergy expenses.

Medical flexible spending accounts (FSAs) have been a staple of the employee-benefits world for more than 40 years, allowing workers to help reduce taxable income and set aside pre-tax money to use on costs not already covered by health insurance.

Read more: Medical FSAs: ‘Use it or lose it’ time is here

Health savings accounts are another tax-advantaged way for people to earmark medical money. An account can offer triple tax advantages, with its contributions, any earnings, and withdrawals being free of federal income tax if used to pay for qualified medical expenses.

variety of OTC allergy medications are covered by FSAs and HSAs, along with prescription drug costs and copays.11

Spending money to stay well can be a good investment: Over a third of people (35%) say their physical wellbeing is how they define success, according to Empower research.

Breathing freely

Even for those battling allergies, people don’t want to be held back from spending time outside: As of 2023, around 57% of the U.S. population participates annually in an average of 62.5 outdoor recreation outings each.

Even getting outside to do chores can brighten the day, with 25% of Americans saying that maintaining their lawn makes them happy.

Read more: Grass is getting greener: A lawn maintenance cost checkup

With most of the country expected to see a dry, warm spring in 2025, pollen could linger, though different conditions could affect the count. Rain could wash allergens away, while higher humidity levels may prevent particles from sticking around.12

While the intensity of this year’s allergy season is still up in the air, getting clarity on making the most of expenses isn’t anything to sneeze at.

Get financially happy

Put your money to work for life and play

1 CBS News, “Spring allergies are here for 2025, and this map shows which U.S. cities could be hit hardest,” March 2025.

2 Centers for Disease Control and Prevention, “Allergens and Pollen,” accessed March 2025.

3 GlobeNewswire, “The Allergy Treatment Market is Set to Reach USD 42.7 Billion by 2034 with a 7.2% of CAGR, driven by Innovation and Increasing Demand for Advanced Therapeutic Solutions | Future Market Insights, Inc.,” January 2025.

4 Numerator, “Sneezing the Opportunity: Seasonal Consumer Trends in OTC Allergy Medications,” September 2024.

5 Numerator, “Sneezing the Opportunity: Seasonal Consumer Trends in OTC Allergy Medications,” September 2024.

6 Emarketer, “US Healthcare and Pharma Ad Spending 2024,” October 2024.

7 DesignRush, “Allegra Collaborates with Disney’s 'Snow White' to Combat Seasonal Allergies,” February 2025.

8 Cleveland Clinic, “Allergy Shots,” accessed March 2025.

9 Cleveland Clinic, “Allergy Shots,” accessed March 2025.

10 Centers for Medicare & Medicaid Services, "National health expenditure data,” accessed March 2025.

11 GoodRx, “How to Use Your FSA or HSA for Allergy Products,” April 2023.

12 Fox 7 Austin, “Pollen reaches high to extreme levels across southern US as season reaches full throttle,” March 2025.

RO4362220-0325

The Currency editors

Staff contributors

The CurrencyTM, a publication from Empower, covers the latest financial news and views shaping how we live, work, and play. We keep you current on ways to plan, save, and invest for life.

The content contained in this blog post is intended for general informational purposes only and is not meant to constitute legal, tax, accounting or investment advice. You should consult a qualified legal or tax professional regarding your specific situation. No part of this blog, nor the links contained therein is a solicitation or offer to sell securities. Compensation for freelance contributions not to exceed $1,250. Third-party data is obtained from sources believed to be reliable; however, Empower cannot guarantee the accuracy, timeliness, completeness or fitness of this data for any particular purpose. Third-party links are provided solely as a convenience and do not imply an affiliation, endorsement or approval by Empower of the contents on such third-party websites. This article is based on current events, research, and developments at the time of publication, which may change over time.

Certain sections of this blog may contain forward-looking statements that are based on our reasonable expectations, estimates, projections and assumptions. Past performance is not a guarantee of future return, nor is it indicative of future performance. Investing involves risk. The value of your investment will fluctuate and you may lose money. 

Certified Financial Planner Board of Standards Inc. (CFP Board) owns the certification marks CFP®, CERTIFIED FINANCIAL PLANNER™, CFP® (with plaque design), and CFP® (with flame design) in the U.S., which it authorizes use of by individuals who successfully complete CFP Board's initial and ongoing certification requirements.